RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Lots of good gouge in this article.I also think it's beneficial for Medipharm Labs to keep cannabis on Schedule 1 in the US, because if their generic of Epidiolex is approved, it would automatically be on Schedule 5, just like Epidiolex itself. This means that the other manufacturers of CBD would not be medically recognised and the US market would remain closed to them.